FDA Holds Off Approval of New Merck Arthritis Drug  NEW YORK (Reuters) - Merck   Co. on Friday said U.S.  regulators won't approve its experimental arthritis drug  Arcoxia until the company provides more data showing it is safe  and effective. 
What label best describes this news article? 